HK-listed China Isotope jumps most in near two years on earnings optimism

China Isotope & Radiation

16/01/2023 06:56

** Shares of radiopharmaceuticals products maker China
Isotope & Radiation Corp  1763.HK  jump as much as 16.7% to
HK$15.40, on course for the biggest daily pct rise since
February 2021, if gains hold
    ** Stock hits highest since Dec. 13 for a third straight
session of gain
    ** Beijing-based company expects its 2022 revenue to rise
between 17% and 22% year-on-year to 6.02-6.27 bln yuan
($897.66-$934.94 mln) and net profit to climb 13-19%
year-on-year to 376-399 mln yuan, thanks to growth on
pharmaceuticals, radioactive sources and radiation therapy
equipment businesses 
    ** The Hang Seng Commerce & Industry Index  .HSNC  falls
1.3% while the healthcare index  .HSCIH  climbs 0.6%
    ** The Hang Seng Composite Index  .HSCI  slips 0.6% and the
Hang Seng Index  .HSI  eases 0.7%
($1 = 6.7063 Chinese yuan renminbi)
 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))